Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Wells Fargo analysts reiterated a Overweight rating on Monolithic Power Systems, Inc. (NASDAQ:MPWR) on July 20, 2026. Market Context Monolithic Power Systems, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Cardinal Health, Inc. (NYSE:CAH) on July 20, 2026. Market Context Cardinal Health, Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Datadog, Inc. (NASDAQ:DDOG) on July 20, 2026. Market Context Datadog, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Datadog, Inc. (NASDAQ:DDOG) on July 20, 2026. Market Context Datadog, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Datadog, Inc. (NASDAQ:DDOG) on July 20, 2026. Market Context Datadog, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Nasdaq, Inc. (NASDAQ:NDAQ) on July 20, 2026. Market Context Nasdaq, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on Private Bancorp of America, Inc. (OTC:PBAM) on July 20, 2026. Market Context Private Bancorp of America, Inc.
Read moreRating Change DA Davidson analysts reiterated a Buy rating on Private Bancorp of America, Inc. (OTC:PBAM) on July 20, 2026. Market Context Private Bancorp of America, Inc.
Read moreRating Change Benchmark analysts reiterated a Buy rating on Exodus Movement, Inc. (AMEX:EXOD) on July 20, 2026. Market Context Exodus Movement, Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on 4D Molecular Therapeutics, Inc. Common Stock (NASDAQ:FDMT) on July 20, 2026.
Read moreRating Change Lake Street analysts downgraded Personalis, Inc. (NASDAQ:PSNL) from Buy to Hold on July 20, 2026. Market Context Personalis, Inc.
Read moreRating Change BTIG analysts reiterated a Buy rating on Personalis, Inc. (NASDAQ:PSNL) on July 20, 2026. Market Context Personalis, Inc.
Read moreRating Change Needham analysts downgraded Personalis, Inc. (NASDAQ:PSNL) from Buy to Hold on July 20, 2026. Market Context Personalis, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Sweetgreen, Inc. (NYSE:SG) on July 20, 2026. Market Context Sweetgreen, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on BJ's Restaurants, Inc. (NASDAQ:BJRI) on July 20, 2026. Market Context BJ's Restaurants, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Omada Health (NASDAQ:OMDA) on July 20, 2026. Market Context Omada Health operates in the Healthcare…
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on Bowhead Specialty Holdings Inc. (NYSE:BOW) on July 20, 2026. Market Context Bowhead Specialty Holdings Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on MoonLake Immunotherapeutics (NASDAQ:MLTX) on July 20, 2026. Market Context MoonLake Immunotherapeutics…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Trevi Therapeutics, Inc. Common Stock (NASDAQ:TRVI) on July 20, 2026.
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on Trevi Therapeutics, Inc. Common Stock (NASDAQ:TRVI) on July 20, 2026.
Read more
